Phase 1 Trial of Human Chimeric Antigen Receptor Modified T Cells (huCART-meso) Administered in Combination with Oncolytic Virus VCN-01 in Patients with Pancreatic and Ovarian Cancer.
huCART-meso;VCN-01
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Phase 1 Trial of Human Chimeric Antigen Receptor Modified T Cells (huCART-meso) Administered in Combination with Oncolytic Virus VCN-01 in Patients with Pancreatic and Ovarian Cancer. ### Output: huCART-meso;VCN-01